Eylea 2 MG/0.05 ML vial 0.05ML
Ended Awarded
- Contract number
- SPE2DB25FKEJW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,770
Award facts
- Contract value 100% obligated
- $3,770.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,770.31 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for EYLEA 2 mg/0.05 mL vials on August 7, 2025, with an ultimate completion date of August 28, 2025. EYLEA is a prescription anti-vascular endothelial growth factor medication used to treat age-related macular degeneration and other retinal conditions. The contract was performed in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters. No set-aside designation was utilized for this award, and the order was issued without a specific set-aside classification.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler, serves as a critical supplier in the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company has maintained an active federal contracting relationship since its registration with the System for Award Management in 2001 and has secured numerous delivery orders across a diverse portfolio of pharmaceutical products supporting military health system requirements.
Quick answers
Who was awarded contract SPE2DB25FKEJW?
SPE2DB25FKEJW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FKEJW worth?
The government has obligated $3,770 on SPE2DB25FKEJW.
Is contract SPE2DB25FKEJW an order under another contract?
Yes. SPE2DB25FKEJW is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEJW competed?
The extent of competition for SPE2DB25FKEJW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award